Filing Details

Accession Number:
0001731122-21-000286
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-23 13:22:55
Reporting Period:
2021-02-19
Accepted Time:
2021-02-23 13:22:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1314052 Anavex Life Sciences Corp. AVXL Services-Commercial Physical & Biological Research (8731) 208365999
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1698234 D.o. Peter Donhauser 51 W 52Nd Street, 7Th Floor
New York NY 10019-6163
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-19 1,000 $12.62 1,000 No 4 P Direct
Common Stock Acquisiton 2021-02-19 165 $12.97 1,165 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct